A Retrospective Study of the Navio Robotic-assisted Surgical System (NAVIO)
A Retrospective Study of the Navio™ Robotic-assisted Surgical System
研究概览
地位
详细说明
研究类型
注册 (实际的)
联系人和位置
学习地点
-
-
Arizona
-
Phoenix、Arizona、美国、85016
- Hedley Orthopedics
-
-
California
-
Santa Barbara、California、美国、93105
- Santa Barbara Cottage Hospital
-
-
Michigan
-
Battle Creek、Michigan、美国、49015
- Bronson Orthopedic Specialists
-
-
Ohio
-
New Albany、Ohio、美国、43054
- OrthoNeuro New Albany
-
-
Pennsylvania
-
Philadelphia、Pennsylvania、美国、19107
- Rothman Institute
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
描述
Inclusion Criteria:
- Male or female subjects ≥ 18 years old (at the time of surgery) who have undergone Navio System-assisted UKR at least 2 years prior to enrollment. This includes UKR procedures with all Unicondylar Knee cemented implant designs.
- Subject had a primary diagnosis of unicompartmental, non-inflammatory degenerative joint disease including osteoarthritis, traumatic arthritis, or avascular necrosis, required correction of functional deformity, or required treatment of fractures that were unmanageable using other techniques.
Exclusion Criteria:
- Subject received the Navio System-assisted UKR on the index joint as a revision for a previously failed UKR.
- Subject, in the opinion of the Investigator, had advanced osteoarthritis or joint disease at the time of surgery and was better suited for Total Knee Arthroplasty (TKA).
- Subject, in the opinion of the Investigator, had a neuromuscular disorder that prohibited control of the index joint.
- Subject, in the opinion of the Investigator, was morbidly obese.
- Subject, in the opinion of the Investigator, was contraindicated for UKR.
- Subject (prospective subjects only), in the opinion of the Investigator, has an emotional or neurological condition including mental illness, mental retardation, drug or alcohol abuse.
- Subject (prospective subjects only) is a prisoner.
学习计划
研究是如何设计的?
设计细节
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
---|---|---|
Evaluate the Navio™ System for Revisions at 2+ Years Post-surgical Implantation Survivorship
大体时间:Preoperative (Baseline) and 24, 48, 72, 96, and 120 weeks postoperatively
|
Analysis of the absence of device revision (overall survivorship) outcomes assessed from Baseline through 120 weeks post-surgical implantation.
|
Preoperative (Baseline) and 24, 48, 72, 96, and 120 weeks postoperatively
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
---|---|---|
Evaluation of Efficacy Based on Knee Society Score (KSS) Assessments
大体时间:Preoperative (Baseline) and 6, 12, 18, 24, 30, and 36 months postoperatively
|
Analysis of KSS from preoperatively (Baseline) up to 36 months postoperatively in 6-months increments to evaluate objective observation, patient satisfaction, and function. Objective knee indicators: Range 0-100 points; Patient Satisfaction: Range 0-40 points; and Functional Activities: Range 0-100 points. Higher scores indicated a better outcome. |
Preoperative (Baseline) and 6, 12, 18, 24, 30, and 36 months postoperatively
|
Evaluation of Efficacy Based on Veterans RAND 12 (VR-12) Assessments
大体时间:Preoperative (Baseline) and 6, 12, 18, 24, 30, and 36 months postoperatively
|
Analysis of VR-12 scores preoperatively (Baseline) through 36 months postoperatively in 6 months increments. These scores encompass the individual domains of physical component score (PCS), mental component score (MCS) as well as the sub-domain scores within the PCS (physical functioning, role physical, bodily pain, and general health) and those within the MCS (vitality, social functioning, role emotional, and mental health). Domain Scores: Physical Component Score (PCS): Range 1 to 20 Mental Component Score (MCS): Range 1 to 25 Sub-domain Scores: Physical Functioning: Range 1 to 6 Role Physical: Range 1 to 4 Bodily Pain: Range 1 to 6 General Health: Range 1 to 6 Vitality: Range 1 to 6 Social Functioning: Range 1 to 6 Role Emotional: Range 1 to 4 Mental Health: Range 1 to 10 Transformation of raw scale scores (range 0-100) = {(actual raw score - lowest possible raw score)/possible raw score range} x100 A higher score indicates a better outcome. |
Preoperative (Baseline) and 6, 12, 18, 24, 30, and 36 months postoperatively
|
Preoperative Evaluation of Efficacy Based on Radiographic Findings
大体时间:Preoperative (Baseline)
|
Changes in radiographic findings (anterior-posterior [AP] and lateral x-rays) from Baseline to 3 years postoperatively were collected for the SAF population.
|
Preoperative (Baseline)
|
Postoperative 6-Month Evaluation of Efficacy Based on Radiographic Findings
大体时间:6 months postoperatively
|
Changes in radiographic findings (AP and lateral x-rays) from Baseline to 3 years postoperatively were collected for the SAF population.
|
6 months postoperatively
|
Postoperative 12-Month Evaluation of Efficacy Based on Radiographic Findings
大体时间:12 months postoperatively
|
Changes in radiographic findings (AP and lateral x-rays) from Baseline to 3 years postoperatively were collected for the SAF population.
|
12 months postoperatively
|
Postoperative 18-Month Evaluation of Efficacy Based on Radiographic Findings
大体时间:18 months postoperatively
|
Changes in radiographic findings (AP and lateral x-rays) from Baseline to 3 years postoperatively were collected for the SAF population.
|
18 months postoperatively
|
Postoperative 24-Month Evaluation of Efficacy Based on Radiographic Findings
大体时间:24 months postoperatively
|
Changes in radiographic findings (AP and lateral x-rays) from Baseline to 3 years postoperatively were collected for the SAF population.
|
24 months postoperatively
|
Postoperative 30-Month Evaluation of Efficacy Based on Radiographic Findings
大体时间:30 months postoperatively
|
Changes in radiographic findings (AP and lateral x-rays) from Baseline to 3 years postoperatively were collected for the SAF population.
|
30 months postoperatively
|
Postoperative 36-Month Evaluation of Efficacy Based on Radiographic Findings
大体时间:36 months postoperatively
|
Changes in radiographic findings (AP and lateral x-rays) from Baseline to 3 years postoperatively were collected for the SAF population.
|
36 months postoperatively
|
合作者和调查者
调查人员
- 研究主任:Beate Hanson, MD, PhD、Smith & Nephew, Inc.
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- 16-NPFS-11
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.